<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">Rapid antiretroviral therapy (ART) is a novel strategy to reduce HIV transmission and shorten time to virologic suppression. Rapid ART has been adopted in many cities throughout the United States and typically involves the provision of antiretroviral medications within 7 days of a new diagnosis. Rapid ART, ideally within 24-h of diagnosis, is proving to be crucial in efforts to speed virologic suppression and reduce HIV transmission [
 <xref ref-type="bibr" rid="CR1">1</xref>–
 <xref ref-type="bibr" rid="CR7">7</xref>]. Our national plan: “Ending the HIV Epidemic: A Plan for America” aims to improve quality of life for people living with HIV (PLWH) through early diagnosis and rapid and effective treatment to achieve and maintain viral suppression [
 <xref ref-type="bibr" rid="CR8">8</xref>, 
 <xref ref-type="bibr" rid="CR9">9</xref>]. Recommendations that ART should be initiated within 7 days of HIV diagnosis have been adopted by the World Health Organization (WHO) and International AIDS Society-USA (IAS-USA) [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR3">3</xref>]. The Department of Health and Human Services (DHHS) also recommends the immediate initiation of ART therapy due to the significant increase in viral suppression amongst patients from the START and TEMPRANO randomized trials who began immediate ART or initiated therapy within 7 days [
 <xref ref-type="bibr" rid="CR10">10</xref>].
</p>
